Does TOFACITINIB Cause Oedema peripheral? 1,158 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,158 reports of Oedema peripheral have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.7% of all adverse event reports for TOFACITINIB.
1,158
Reports of Oedema peripheral with TOFACITINIB
0.7%
of all TOFACITINIB reports
501
Deaths
572
Hospitalizations
How Dangerous Is Oedema peripheral From TOFACITINIB?
Of the 1,158 reports, 501 (43.3%) resulted in death, 572 (49.4%) required hospitalization, and 491 (42.4%) were considered life-threatening.
Is Oedema peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 1,158 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Oedema peripheral?
AMBRISENTAN (2,959)
TREPROSTINIL (2,816)
ADALIMUMAB (2,356)
LENALIDOMIDE (2,298)
AMLODIPINE (2,076)
PREDNISONE (2,029)
METHOTREXATE (1,939)
MACITENTAN (1,932)
RITUXIMAB (1,698)
TOCILIZUMAB (1,574)
Which TOFACITINIB Alternatives Have Lower Oedema peripheral Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN